SCGB1A1 and acute respiratory distress syndrome: In the latter category, two plasma biomarkers (Club cell protein 16 and soluble receptor for advanced glycation end-products) and two panels of breath metabolites were found to discriminate ARDS patients with good accuracy [15, 26, 30, 31].